Humoral and cellular immunity against different SARS-CoV-2 variants in patients with chronic kidney disease

Chronic kidney disease (CKD) patients are at higher risk of severe COVID-19. Humoral and cellular immunity from prior infection or vaccination are important for protection, but the neutralizing antibody (nAb) response against SARS-CoV-2 variants is impaired. We investigated the variant-specific nAb...

Descripción completa

Detalles Bibliográficos
Autores principales: Yap, Desmond Yat-Hin, Fong, Carol Ho-Yan, Zhang, Xiaojuan, Ip, Jonathan Daniel, Chan, Wan-Mui, Chu, Allen Wing-Ho, Chen, Lin-Lei, Zhao, Yan, Chan, Brian Pui-Chun, Luk, Kristine Shik, Cheng, Vincent Chi-Chung, Chan, Tak-Mao, To, Kelvin Kai-Wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652016/
https://www.ncbi.nlm.nih.gov/pubmed/37968273
http://dx.doi.org/10.1038/s41598-023-47130-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652016/
https://www.ncbi.nlm.nih.gov/pubmed/37968273
http://dx.doi.org/10.1038/s41598-023-47130-8

Ejemplares similares